Lymphoma case studies

Click here for latest presentation

The Perseus Foundation is delighted and excited to be able to share Dr. Kevin Steele's "Adoptive T-Cell Therapy for Lymphoma: The Clinician's Guide."

A reference guide for treating Lymphoma in vivo immunization.

To view this presentation please click here

as a registered 501(c)3, all donations to the perseus foundation are tax deductible

ein: 31.1658057

Anivive Announces FDA Conditional Approval of LAVERDIA™-CA1 (verdinexor) - the First and Only Oral Tablet to Treat Lymphoma in Dogs

- LAVERDIA-CA1 uses new, targeted SINE technology to treat B-cell and T-cell lymphoma

- New approach allows twice weekly oral administration at home, and affordable price point expands access to cancer care.

www.anivive.com

News and Newsworthy. 04.01.11

After leading the research and development of VolitionRx Limited’s (Volition) Nu.Q Vet Cancer Screening Test, the Texas A&M University College of Veterinary Medicine & Biomedical Sciences (CVMBS) will now offer the newly launched, easy-to-use, cost-effective cancer test through the CVMBS’ Gastrointestinal (GI) Laboratory

For educational material please click here.

Video: https://youtu.be/x2IIn2Owj7Y

For additional information please click here.

Treatment is Within Reach For You and Your Patients.

When current treatment options aren’t right for pets with cancer, Torigen offers a different solution. Torigen creates personalized cancer immunotherapies utilizing a portion of surgically resected tumor sent into our laboratories. This new approach is tailored for each patient and helps in the fight against cancer.  

Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.

To learn more please click here.